MiniMed Group, Inc. Common Stock
MMED
Rang in aandelen
#3401
MiniMed Group, Inc. specializes in designing, producing, and distributing a... MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Aandeelprijs
$17.87
Laatst gesynchroniseerd: 2026-10-21
Marktkapitalisatie
$5.03B
Verandering (1 dag)
2.14%
Verandering (1 jaar)
-
Land
US
Handel MiniMed Group, Inc. Common Stock (MMED)
Categorie
Healthcare
P/B-ratio voor MiniMed Group, Inc. Common Stock (MMED)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van MiniMed Group, Inc. Common Stock is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor MiniMed Group, Inc. Common Stock van 2023 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2025 | 1.56 | 3.51% |
| 2024 | 1.51 | 0.00% |
| 2023 | 0.00 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| 19.8228 | - |
US
|
|
| - | - |
US
|
|
| - | - |
US
|
|
| 27.8715 | - |
IL
|
|
| 3.7809 | - |
US
|
